Related Experiment Video
Updated: Jun 21, 2025

05:18
Quantification of Immunostained Caspase-9 in Retinal Tissue
Published on: July 25, 2022
1.4K
Brief research report: ETS-1 blockade increases ICAM-1 expression in activated human retinal endothelial cells
Alwin Chun Rong Tan1, Yuefang Ma1, Binoy Appukuttan1
1Flinders University College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Frontiers in Ophthalmology
|July 10, 2024
Summary
Blocking ETS-1, a transcription factor, unexpectedly increases Intercellular Adhesion Molecule 1 (ICAM-1) in retinal cells. This suggests ETS-1 targeting may worsen leukocyte migration in non-infectious posterior uveitis.
Area of Science:
- Ophthalmology
- Immunology
- Molecular Biology
Background:
- Intercellular Adhesion Molecule 1 (ICAM-1) is crucial for leukocyte migration in non-infectious posterior uveitis.
- Inhibiting ICAM1 gene transcription can reduce ICAM-1 levels in inflamed retinal endothelium.
- Transcription factor ETS-1 is implicated as an activator of ICAM1 gene transcription.
Purpose of the Study:
- To investigate the effect of ETS-1 blockade on ICAM-1 levels in cytokine-stimulated human retinal endothelial cells.
- To determine if targeting ETS-1 can reduce ICAM-1 expression and subsequent leukocyte migration.
Main Methods:
- Human retinal endothelial cells were stimulated with TNF-α or IL-1β.
- ETS-1 expression was analyzed via transcript expression.
- ETS-1 blockade was achieved using small interfering (si)RNA.
- ICAM-1 transcript and protein levels were quantified post-ETS-1 blockade.
Main Results:
- Cytokine stimulation (TNF-α, IL-1β) increased both ICAM1 and ETS1 transcripts in retinal endothelial cells.
- ETS-1 blockade via siRNA significantly reduced ETS1 transcript levels (>90%).
- Unexpectedly, ETS-1 blockade increased both ICAM-1 transcript and membrane-bound protein levels.
Conclusions:
- ETS-1 blockade unexpectedly upregulates ICAM-1 transcript and protein in human retinal endothelial cells.
- Targeting ETS-1 is unlikely to inhibit, and may instead promote, leukocyte migration in non-infectious posterior uveitis.
- These findings challenge the therapeutic potential of ETS-1 inhibition for this condition.

